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ABSTRACT
Xeroderma pigmentosum (XP) is an autosomal
recessive genetic disorder. Afflicted patients show
extreme sun-sensitivity and skin cancer predispo-
sition. XP is in most cases associated with defi-
cient nucleotide excision repair (NER), which is the
process responsible for removing photolesions
from DNA. Measuring NER activity by nucleotide
incorporation into repair patches, termed ‘unsched-
uled DNA synthesis (UDS)’, is one of the most
commonly used assays for XP-diagnosis and NER
research. We have established a rapid and accurate
procedure for measuring UDS by replacement of
thymidine with 5-ethynyl-2’-deoxyuridine (EdU).
EdU incorporated into repair patches can be directly
conjugated to fluorescent azide derivatives, thereby
obviating the need for either radiolabeled thy-
midine or denaturation and antibody detection of
incorporated bromodeoxyuridine (BrdU). We dem-
onstrate that the EdU incorporation assay is com-
patible with conventional techniques such as
immunofluorescent staining and labeling of cells
with micro-latex beads. Importantly, we can com-
plete the entire UDS assay within half a day from
preparation of the assay coverslips; this technique
may prove useful as a method for XP diagnosis.
INTRODUCTION
Cells are continuously exposed to various types of DNA
damage induced by both endogenous and exogenous
sources. Consequently, all living organisms have devel-
oped DNA repair mechanisms to ensure that the integrity
of the genetic information is maintained (1). Nucleotide
excision repair (NER) is one of the most versatile DNA
repair systems, which deals with the major UV photo-
products, as well as many DNA adducts arising from
exposure to a variety of chemical carcinogens (2,3).
NER involves removal of damaged nucleotides from
the DNA by dual incisions, and ﬁlling and sealing of the
residual single-strand gaps by DNA polymerases and
ligases (1–3).
Xeroderma pigmentosum (XP) is the prototype NER-
deﬁcient genetic disorder (2–4), the incidence of which is
1 in 80000 to 1000000 in the general population, depend-
ing on the location (5). XP patients suﬀer from severe
photosensitivity, a high incidence of sunlight-induced
skin cancer and in some cases neurological abnormalities.
In  80% of XP cases, the patients have a defect in one
of the genes responsible for NER. XP-variant patients,
who comprise the residual 20% of XP cases, are proﬁ-
cient in NER but have a defect in post-replication repair
(PRR) as they lack the specialized DNA polymerase,
polZ, which accurately replicates past cyclobutane pyrimi-
dine dimers (CPDs) (6).
Cockayne syndrome (CS) and Trichothiodystrophy
(TTD) are also NER-deﬁcient disorders (4,7,8). NER
consists of two sub-pathways: global genome repair
(GGR) is relatively slow but functions genome wide (3),
whereas transcription-coupled repair (TCR) is a faster
process that is specialized for the transcribed strand of
actively transcribed regions (9,10). With the exception
of XPC and XPE, which are used exclusively in GGR
(3), all genes defective in patients with XP, the combined
features of XP and CS (XP/CS), and TTD are associated
with both pathways, whereas in CS only TCR is compro-
mised (7,9–11). NER-deﬁcient patients have been so far
assigned to at least 11 complementation groups (XP-A to
G, CS-A and B, TTD-A and ERCC1), which correspond
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proteins (3,4).
The most commonly used assay for assessing NER-
deﬁciency entails measuring nucleotide incorporation
levels associated with DNA-repair activity. GGR, which
contributes to  90% of NER activity, is assessed by
damage induced non-S-phase gap-ﬁlling DNA replication,
termed ‘unscheduled DNA synthesis (UDS)’ (12), while
TCR activity can be measured by ‘recovery of RNA
synthesis (RRS)’ levels after DNA-damaging treatment
(13). Currently, a variety of methods for measuring
UDS have been established (8,12,14–17). For inducing
DNA damage 254-nm UVC-irradiation is commonly
used and cells are then incubated in the presence of
either radiolabeled thymidine or a nucleoside analog.
The most frequently used methods in XP-diagnostic
laboratories are: (i)
3H-thymidine incorporation, followed
by evaluation of grain counting after autoradiography of
tissue-culture coverslips—this technique is accurate and
compatible with most immunostaining-based methods,
but the procedures are labor-intensive and time-
consuming (15,16). (ii) Bromodeoxyuridine (BrdU) incor-
poration, followed by alkaline denaturation of DNA, and
immunoﬂuorescent detection by anti-BrdU antibody—
this is a convenient variant of method (i); replacement of
3H-thymidine by BrdU diminishes the time needed for
the assay, however it has reduced sensitivity ( 50% reduc-
tion of UDS activity is not detectable) (18). (iii) Liquid
scintillation counting of
3H-thymidine incorporation into
repair patches—although this method is rapid, the quan-
titative capacity is lower than the other methods as this
is a batch assay. Furthermore, replicative DNA synthesis
has to be abolished by using non-dividing cells and the
DNA replication inhibitor, hydroxyurea (HU), during
the assay (12).
In this report, we have employed 5-ethynyl-20-deoxyuri-
dine (EdU), an alkyne-conjugated nucleoside analogue
of thymidine, as an alternative to radioactive thymidine
or BrdU (19). In contrast to the BrdU-based UDS assay,
EdU can be directly conjugated to ﬂuorescent azide (20),
and thus, the assay does not require denaturing of DNA
nor the use of antibodies. We have successfully improved
the sensitivity, which is one of the weak points of
BrdU-based methods. Furthermore, the total time for
the assay was dramatically reduced even compared to
the BrdU-based assay. Using this technique, a standard
UDS assay can be completed within half a day from
preparation of the assay coverslips.
MATERIALS AND METHODS
Cellstrains and cultures
All the cells used in this report are human primary
ﬁbroblasts. Normal 1BR (21), 48BR (21), 142BR (22)
and 251BR (22), XP-patient-derived XP12BR (XP-D)
(this study), XP15BR (XP-A) (22), XP13BR (XP-C)
(this study) and XP20BE (XP-G) (23) and CS-patient-
derived CS10LO (CS-B) (24) cells were used. Cells
were cultured in Dulbecco’s Modiﬁed Eagle Medium
(DMEM) supplemented with 10% FBS (Gibco-BRL)
and penicillin–streptomycin (Wako), and maintained at
semi-conﬂuent density during the experiments unless oth-
erwise stated. For labeling with latex-beads, 48BR cells
were cultured with a few drops of 0.5-mm diameter poly-
bead Hydroxylate (Polysciences) in DMEM for 3 days.
UV-induced UDS measurement in normalprimary human
fibroblasts by EdU incorporation
5-ethynyl-20-deoxyuridine (EdU) is available from
Invitrogen (19). To optimize UV-induced UDS by EdU
incorporation, eﬀects of UV dose and EdU-incubation
period were examined. 48BR cells were cultured on cover-
slips and maintained at conﬂuent density. Cells were
washed with PBS, followed by irradiation with diﬀerent
doses (5–20J/m
2) of UVC (254nm). After UV irradiation,
cells were immediately incubated with serum-free DMEM
supplemented with 10mM EdU for diﬀerent periods (0.5,
1, 2 and 4h). Serum-free medium was used since serum
often contains thymidine, which competes with EdU for
incorporation into DNA. Cells were then washed with
PBS, followed by ﬁxation and permeabilization with
PBS containing 2% formaldehyde, 0.5% triton X-100
and 300mM sucrose for 20min. After extensive washing
with PBS, cells were blocked with 10% FBS in PBS for
30min. Incorporated EdU was detected by ﬂuorescent-
azide coupling reaction (Click-iT, Invitrogen) (19).
Brieﬂy, cells were incubated for 30min with azide-
conjugated Alexa Fluor 488 dye in TBS supplemented
with 4mM CuSO4. Cells were then washed three times
with PBS containing 0.05% Tween-20 (PBST).
Coverslips were ﬁnally soaked with PBS, ﬁxed with
3.7% formaldehyde in PBS for 20min, and mounted
on glass slides with Aquapolymount (Polysciences).
Photographs of the cells were captured with a ﬂuorescent
microscope equipped with a CCD camera
(BIOREVO9000-KEYENCE), and captured images were
processed and analysed with ImageJ software (NIH). At
least 50 non-S-phase cells were randomly selected from a
single captured ﬁeld, and the average nuclear ﬂuorescent
intensity was calculated. Data points presented in the text
are the averages calculated from ﬁve diﬀerent ﬁelds.
We found that 20J/m
2 UV irradiation followed by 2-h
EdU incubation was the optimal condition for the UDS
assay. This condition was used for all experiments except
for Figures 1A and 5.
BrdU incorporation assay
Cells were cultured and UVC irradiated (20J/m
2), and
incubated in conditions identical to the EdU-incorpora-
tion assay described above (5mM BrdU, instead of
EdU, was supplemented). Cells were then washed with
PBS, followed by ﬁxation and permeabilization in PBS
containing 2% formaldehyde, 0.5% tritonX-100 and
300mM sucrose for 20min. After extensive washing with
PBS, cells were treated with 4M HCl in PBS for 15min for
denaturing DNA. Cells were extensively washed with PBS
for neutralization, followed by blocking with 10% FBS in
PBS for 30min. Incorporated BrdU was detected by 1-h
incubation with mouse anti-BrdU antibody (BD, diluted
1:150 in PBST). Cells were then washed three times with
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conjugated goat anti-mouse IgG (Invitrogen, diluted 1:500
in PBST). Coverslips were ﬁnally soaked in PBS,
ﬁxed with 3.7% formaldehyde in PBS for 20min,
and mounted on glass slides with Aquapolymount
(Polysciences). Image capture and analyses were per-
formed as described above.
3H-thymidine incorporation assay
Details of the assay have been previously described (12).
Cells were cultured in 1% DMEM for 3 days (3 10
5cells
per 5-cm-diameter dish). They were then incubated for 1h
with 10mM hydroxyurea (HU), UV irradiated and incu-
bated for a further 3h with 1% DMEM containing
10mCi/ml
3H-thymidine and 10mM HU.
3H-thymidine
incorporated into acid-insoluble materials was measured
by liquid scintillation counting.
Immunostaining
48BR and XP20BE cells were mix-cultured at 1:1 ratio
(48BR alone for ki67 staining). UV irradiation, EdU incu-
bation and ﬁxing and permeabilization steps were as
described above. For antibody detection, cells were
blocked with 10% FBS in PBS for 30min, followed by
1-h incubation with mouse monoclonal anti-XPG (8H7,
Santa Cruz Biotechnology), or rabbit monoclonal anti-
ki67 (SP6, Thermo scientiﬁc) antibodies (diluted 1:100 in
PBST). Cells were then washed three times with PBST,
followed by 1-h incubation with secondary antibodies:
Alexa Fluor 594-conjugated goat-anti-mouse-, and goat-
anti-rabbit-IgG, for XPG and ki67 detection, respectively
(Invitrogen, diluted 1:1000 in PBST). To avoid unneces-
sary nuclear ﬂuorescence, DAPI staining was omitted.
After extensive washing with PBST, cells were ﬁxed for
20min with 3.7% formaldehyde in PBS. Subsequently,
EdU detection was carried out as described above.
RESULTS
Effects ofUV dose andEdU-incubation period on
measurement of UV-induced UDS innormal
human primary fibroblasts
48BR normal primary human ﬁbroblasts were cultured
on coverslips and subsequently exposed to diﬀerent
doses of UVC, followed by incorporation of EdU for
diﬀerent time periods. UVC treatment elicited UDS activ-
ity as shown by an increase in nuclear ﬂuorescence, after
conjugation of ﬂuorescent azide to incorporated EdU
(Figure 1A and B). As reported in previous publications
employing
3H-thymidine labeling and autoradiography
(15,16), strong signals from scheduled DNA synthesis in
S-phase cells can be distinguished from much weaker cell-
cycle independent unscheduled EdU incorporation, result-
ing from repair synthesis (Figure 1B). Additionally, the
ﬂuorescent-azide coupling reaction seems speciﬁc to incor-
porated EdU, as we barely detected any non-speciﬁc
cytoplasmic staining or DNA-replication-independent
nuclear signals (Figure 1B). We observed that the nuclear
ﬂuorescent intensities were proportional to both UV dose
and EdU-incubation time, indicating that this end-point
satisfactorily represents the amount of incorporated EdU,
which is directly convertible to semi-quantitative UDS
measurement (Figure 1A). We were able to detect nuclear
ﬂuorescent signals at relatively low UV exposures, and
with short time-periods of post-UV EdU incubation,
demonstrating that this technique is sensitive enough to
detect low levels of UDS activity.
Sensitivity and resolution ofthe EdU-based UDS assay
We evaluated the resolution as well as the sensitivity of the
EdU-based UDS assay, by comparing the results obtained
from the EdU technique with that of conventional auto-
radiography and BrdU-based methods. Many publica-
tions that have utilized autoradiography for the UDS
assay report UDS levels for the most severe XP cases
(i.e. XP-A or XP-G/CS) as <5–10% of normal levels
(25). These can be distinguished from cell strains from
XP patients, typically from XP-C or XP-D groups,
which often have UDS levels of 20–40% of residual
UDS activity (intermediate UDS level). The intensity-
distribution plots for the EdU-based UDS assay for
both normal 48BR (UDS positive, Figure 1C) and XP-
deﬁcient XP15BR (UDS negative, Figure 1D) ﬁbroblasts
resemble those of published autoradiography-based
experiments, though we acknowledge that the background
UDS levels were relatively higher than that from auto-
radiography (this point is discussed later). The EdU
assay consistently produced a satisfactory SD of 10–15%.
We compared the relative sensitivities of the EdU assay
and the BrdU-based method. Though BrdU has been
commonly used for S-phase labeling, publications using
it for UDS assays are quite limited because of
its restricted sensitivity and resolution (18) (Figure 1E
and F). Although the histograms of normal 48BR and
XP-deﬁcient XP15BR ﬁbroblasts could be discriminated
by the BrdU-based assay (Figure 1E and F), the resolution
as well as SD were both markedly improved in the EdU
method, suggesting that EdU is a more sensitive substitute
for BrdU in the UDS assay.
UV-induced EdU incorporation inNER-deficient
primary fibroblasts
To apply the EdU technique to XP diagnosis, we esti-
mated the levels of UV-induced EdU incorporation in
several NER-deﬁcient primary ﬁbroblasts as well as
normal controls (Figure 2A–G for histograms, and
Figure 2I for typical photos). Since XP is a genetically
heterogenous disorder, both the NER genes aﬀected and
the types of mutations determine the magnitude of the
defect in UDS. We measured UDS in XP15BR (XP-A),
XP20BE (XP-G/CS), XP13BR (XP-C), XP12BR (XP-D)
and CS-patient-derived CS10LO (CS-B) cells, and
compared the results with those obtained using
3H-
thymidine incorporation. With 20J/m
2 UVC irradiation,
we observed substantial UDS in normal ﬁbroblasts, 48BR
(Figure 2A) and 1BR (Figure 2B), as measured by EdU
incorporation. We barely detected any UDS in severe
XP-patient-derived XP15BR (XP-A, Figure 2C) and
XP20BE (XP-G, Figure 2D) ﬁbroblasts, while we detected
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patient-derived XP13BR (Figure 2E) ﬁbroblasts.
XP12BR is homozygous for R511Q mutation in the
XPD gene (our unpublished data), and, as shown in
Figure 2F, we found  40% of normal UDS activity. In
Figure 2H, we show the data obtained with the same set of
cell strains using the
3H-thymidine incorporation. In good
agreement with the EdU assay, UDS was barely detectable
in XP15BR, but were about  20% and  40% of normal
in XP13BR and XP12BR, respectively. These results
show good agreement between the two methods and dem-
onstrate that cells exhibiting intermediate UDS activity
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Figure 1. UV-induced UDS assay in normal human primary ﬁbroblasts. (A) Normal 48BR cells were cultured on coverslips, UVC-irradiated at the
indicated doses, followed by incubation with 10mM EdU for diﬀerent time periods, ﬁxation and conjugation of ﬂuorescent dye to the incorporated
EdU as described in ‘Materials and methods’ section. The intensity of nuclear ﬂuorescence, which is associated with UDS activity, was analysed using
a ﬂuorescence microscope and image-processing software. For each data point, at least 250 nuclei were analysed. Points and error bars indicate
means of discrete nuclei ﬂuorescent intensity and standard errors, respectively. (B) Typical photos of the EdU assay are shown. 48BR cells were UVC
irradiated (20J/m
2, +UV) or mock-treated ( UV), followed by 2-h incubation with EdU. EdU, coupled to Alexa ﬂuor 488-azide; PH, phase
contrast. (C–F) UDS performed by incorporation of EdU (C and D) or BrdU (E and F) was compared. XP15BR cells are primary ﬁbroblasts from
an XP-A patient. Cells were UVC irradiated (20J/m
2), followed by incubation with 10mM EdU or 5mM BrdU for 2h. Bars represent frequencies of
the ﬂuorescence levels in the indicated classes, with (black) or without (white) UVC irradiation. Asterisks indicate the mean values of nuclear
ﬂuorescent intensities, which correspond to the UDS levels.  represents UDS diﬀerence between irradiated and unirradiated samples.
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Figure 2. UV-induced EdU incorporation in non-S-phase cells is NER repair replication speciﬁc. (A–G) Levels of UV-UDS in NER-proﬁcient and
NER-deﬁcient cells were examined. Primary ﬁbroblasts were cultured on coverslips, UVC-irradiated (20J/m
2), followed by 2-h incubation with
10mM EdU. Levels of EdU incorporation were analysed as in Figure 1A and presented as in Figure 1. (H) UDS assay performed by
3H-thymidine
incorporation. Quiescent cells were UVC irradiated at the indicated dose and
3H-thymidine incorporation was measured for 3h after UVC irradi-
ation in the media containing 10mM hydroxyurea. UDS levels were normalized and expressed as percentages of the UDS in the normal cells at
10J/m
2. Mean Normal represents the average UDS levels of the four diﬀerent normal cell lines (1BR, 48BR, 142BR and 251BR). Asterisks indicate
the mean values of nuclear ﬂuorescent intensities, which correspond to the UDS levels.  represents UDS diﬀerence between irradiated and
un-irradiated samples. (I) Typical photos of the EdU incorporation examined in Figure 2A–G are shown (2h after 20J/m
2 UVC irradiation).
Arrows indicate non-S-phase cells. 48BR, normal; 1BR, normal; XP15BR, XP-A; XP20BE, XP-G; XP13BR, XP-C; XP12BR, XP-D; CS10LO, CS-B.
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defects by the EdU-based assay.
We then further examined whether CS-deﬁcient ﬁbro-
blasts were distinguishable from normal cell lines by the
UDS assay. CS is only compromised in the TCR pathway
of NER, and this is not precisely diagnosed by UDS
assays, since the deﬁciency is usually subtle. Though
Figure 2G indicates a modest ( 20%) reduction of the
UDS level compared to the normal ﬁbroblasts, we
cannot conclude this to be signiﬁcant and is likely to fall
within the normal range.
Levels of nuclear ﬂuorescence after UVC irradiation in
severe NER-deﬁcient ﬁbroblasts (Figure 2C and D) were
virtually the same as those in unirradiated samples, sug-
gesting that the background ﬂuorescent signals resulting
from minor EdU incorporation or non-speciﬁc ﬂuorescent
conjugation do not aﬀect the analyses. We conclude that
the EdU-based UDS assay provides a speciﬁc measure-
ment of nucleotide incorporation associated with the
repair synthesis step of NER.
Compatibilities ofthe EdU-based UDS assay
withother techniques
We anticipate applying the EdU-based UDS assay system
to clinical diagnoses, in which rigorous intra-assay con-
trols are required. We therefore assessed the compatibility
of the UDS assay with other standard techniques that
use internal references. We found that ﬂuorescent-azide
conjugation to EdU is fully compatible with immuno-
ﬂuorescent staining (Figure 3A and B).
Co-culture of an index ﬁbroblast as well as a target
under study on the same coverslip provides a rigorous
internal control. In Figure 3A, normal and XPG-deﬁcient
ﬁbroblasts were co-cultured, followed by UV-UDS
assayed in combination with a-XPG immunostaining.
EdU-positive cells (excluding S-phase) perfectly corre-
spond to XPG-positive cells, indicating that two diﬀerent
cell populations can be distinguished in the UDS assay.
Similarly, we examined if there was a cell-cycle prefer-
ence for the EdU assay: co-immunostaining with a prolif-
eration marker, ki-67, demonstrated that UDS can be
detected in quiescent ﬁbroblasts (no Ki67 stain) as well
as proliferating populations (Figure 3B).
As discussed above, the level of the defect in UDS activ-
ity varies between diﬀerent XP patients. Ideally, ascertain-
ing whether a patient is NER compromised is evaluated by
comparing the residual UDS activity of the patient-
derived ﬁbroblast with index cells. For this purpose, in a
practical UDS-based XP diagnosis, normal ﬁbroblasts
have been preloaded with latex-beads in the cytoplasm
and co-cultured with patient-derived ﬁbroblasts. The
‘bead-labeled-cells’ provide an internal standard that can
be detected under phase contrast microscopy which elim-
inates sample-to-sample staining variability (15). We
tested if this technique is also compatible with the EdU
assay. First we checked whether the latex-beads did not
aﬀect the nuclear ﬂuorescent intensity. As shown in
Figure 4A (top panel) and corresponding histogram
(Figure 4B), the ﬂuorescent intensity in 48BR cells
loaded with beads was practically the same as those in
cells without beads, indicating that the beads do not inter-
fere with the EdU-based UDS assay.
Modest (XP12BR; Figure 4A middle panel and 4C) as
well as severe (XP15BR; Figure 4A bottom panel and 4D)
UDS-deﬁcient ﬁbroblasts were both easily distinguishable
from co-cultured 48BR ﬁbroblasts by their nuclear
EdU α XPG PH Merge A
B
EdU α Ki67 PH Merge
Figure 3. EdU assay is compatible with immunostaining. (A) Normal 48BR and XPG-deﬁcient XP20BE ﬁbroblasts were co-cultured on coverslips,
UVC irradiated (20J/m
2), followed by 2-h incubation with 10mM EdU. Fixed cells were then immunostained with rabbit anti-XPG antibody (red),
followed by conjugation of Alexa ﬂuor 488-azide to incorporated EdU (green). (B) UV-induced EdU incorporation in quiescent cells. 48BR cells
were UVC irradiated (20J/m
2), followed by 2-h incubation with 10mM EdU. Fixed cells were then immunostained with rabbit anti-ki67 antibody
(red), followed by conjugation of Alexa ﬂuor 488-azide to incorporated EdU (green). Triangle, normal arrow and diamond arrow indicate S-phase,
G0 and G1 (or G2/M), respectively. Detailed experimental conditions are described in ‘Materials and methods’ section.
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Figure 4. EdU assay in the presence of latex beads. Normal 48BR cells were pre-labeled with 0.5-mm diameter latex beads and co-cultured with
indicated XP ﬁbroblasts (no-beads) on coverslips. Cells were then UVC-irradiated (20J/m
2), followed by 2-h incubation with 10mM EdU. Coverslips
were then processed as in Figure 1. (A) Typical photos are displayed. White and red markings, arrows and arrow heads represent 48BR and indicated
XP cells, and non-S-phase and S-phase cells, respectively. (B–D) Histograms of the UDS assay with the internal standard 48BR and (B) 48BR,
normal; (C) XP12BR, XP-D; and (D) XP15BR, XP-A. Bars represent frequencies as described in Figure 1, with (black, 48BR; blue, XP cell-lines) or
without (white, 48BR; red, XP cell-lines) UVC irradiation. Asterisks indicate the mean values of nuclear ﬂuorescent intensities, which correspond the
UDS levels.  represents UDS diﬀerences with or without UVC irradiation.
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out internal controls were nearly the same (compare
Figure 2A, 2C and 2F with Figure 4B, 4D and 4C), sug-
gesting that the prep-to-prep or coverslip-to-coverslip
variation in the EdU-based assay is small; this may be
an advantage when applying the EdU assay to experi-
ments that are incompatible with the use of an internal
standard (e.g. ﬂuorescent-based high-throughput screen-
ing using GE’s In-Cell-Analyzer or ﬂow cytometry).
Further optimization of theEdU assay
The EdU-based experiments described above are suﬃcient
for routine XP screening as well as many types of NER
research; however, further precise experiments such as dis-
tinguishing between no UDS activity and very low levels
may require higher sensitivity. We have attempted to
increase the speciﬁc EdU uptake as well as to reduce the
non-speciﬁc background. The incorporation of a thymi-
dine analogue into the DNA is dependent on its concen-
tration relative to endogenously synthesized thymine
nucleotides in the nucleotide pool. Fluorodeoxyuridine
(FdU) is an inhibitor of thymidylate synthetase, which
renders the cell dependent on exogenously supplied thy-
midine or its analogues. We therefore used FdU and a
longer incubation period (4h) after UV irradiation.
Additionally, we used stringent acid extraction with
Bouin’s ﬁxative to try and reduce the background. As
shown in Figure 5, although not dramatic, both back-
ground (compare white and red bars and their corre-
sponding asterisks) and UDS-speciﬁc EdU uptake
(compare black and blue bars) were improved.
DISCUSSION
Rapid and accurate assessment of UDS levels is indis-
pensable for clinical XP diagnosis as well as NER
research. In this report, we have described a novel UDS
assay system that provides a very simple method for
measurement of repair-replication activity in human cells.
Orthodox UDS assay methods have been based on
3H-thymidine incorporation (12,15,16). Although a vari-
ety of alternative reagents have been developed, most
XP-diagnosis laboratories still measure UDS by auto-
radiography or direct scintillation counting of incorpo-
rated
3H-thymidine. The biggest disadvantages of using
3H-thymidine for UDS assay is its time-consuming pro-
cedures and the requirement for laboratories designated
for radioactive work.
The autoradiographic process provides an accurate
measurement of UDS activity as each silver grain repre-
sents an individual event of nucleotide incorporation into
a repair patch. However, the experiment is complicated,
requiring signiﬁcant skills, and takes 1–2 weeks to be com-
pleted; furthermore, counting of silver grains under the
microscope is laborious. An alternative procedure uses
direct scintillation counting of
3H-thymidine incorpora-
tion (12). This method requires abrogation of S-phase
DNA replication. To accomplish this, cells are brought
into quiescence by serum starvation, and hydroxyurea is
needed during the nucleotide incorporation period, to
block replicative DNA synthesis. This technique signiﬁ-
cantly reduced the time required for the UDS assay, but
quantitation of UDS is less accurate.
In contrast to the above
3H-thymidine-based methods,
BrdU incorporation assay is faster and a convenient
option. Indeed, BrdU has been frequently used for cell-
cycle analysis applications. On the other hand, regardless
of the type of experiments, denaturation of DNA is
needed to detect the incorporated BrdU as the anti-
BrdU antibody is too big to access the epitope in native
DNA. DNA denaturation and subsequent immunoﬂuo-
rescence detection sometimes generate an ambiguous
staining pattern (data not shown; see high SD in
Figure 1E and F). This is the biggest disadvantage of
the BrdU incorporation assay: nucleotide incorporation
into repair patches based on DNA-repair activity is
quite low and diﬃcult to detect. For this reason, UDS
based on BrdU has not been widely used.
*
*
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Fluorescence intensity (a.u.) 
+FdU with acid extraction (48BR)
∆ = 13.6±1.6
−FdU w/o acid extraction (48BR)
∆ = 10.4±1.0
*
*
Figure 5. Improvement of the sensitivity by FdU supplement, longer incubation and acid extraction. Normal 48BR cells were cultured on coverslips,
UVC irradiated (20J/m
2), followed by incubation with 10mM EdU and 1mM FdU (Sigma) for 4h. Cells were then ﬁxed as indicated in Figure 2.
Acid extraction was performed using Bouin’s ﬁxative (Sigma) for 30min, followed by extensive washing with PBS. Conjugation of ﬂuorescent dye
and detection of EdU signals were identical to the experiments in Figure 2. Bars represent frequencies of the ﬂuorescence levels in indicated classes,
with (black, identical to Figure 2A; blue, + FdU + 4-h incubation + acid extraction) or without (white, identical to Figure 2A; red, + FdU + 4-h
incubation + acid extraction) UVC irradiation. Asterisks indicate the mean values of nuclear ﬂuorescent intensities.  represents UDS diﬀerences
with or without UVC irradiation.
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oped for complementing known problems of S-phase
population labeling by
3H-thymidine and BrdU (19). In
EdU, the methyl group on the 5-position of thymidine is
replaced by an alkyne group, and this analogue is incor-
porated into DNA during replication. Subsequent ﬂuo-
rescent-azide coupling, termed ‘click reaction’ is rapid,
sensitive and speciﬁc (19,20); because of this property,
the sensitivity and background ﬂuorescent signal were
both dramatically improved, and hence, EdU can be
used for the UDS assay.
We have presented data demonstrating the usefulness of
EdU for the UDS assay. Although the sensitivity of the
EdU-based method is not as high as the autoradiographic
technique, we easily detected the defect in an XP-D cell
line with  40% residual UDS activity and based on our
data we conservatively estimate that we can detect a level
of 10–20% of normal UDS.
The EdU-based UDS assay may have an advantage in
high-throughput XP diagnosis using ﬂow cytometry. An
attempt to use BrdU labeling and ﬂow cytometry for UDS
has been reported (14). Because of the improved sensitivity
of EdU over BrdU, further introduction of multi-color
labeling (i.e. normal internal control as well as specimen
cells, with or without UV damage, all labeled with diﬀer-
ent ﬂuorescent dyes) may provide a rapid and precise
determination of the relative UDS levels.
In this report, we have demonstrated that: (i) the accu-
racy and resolution of the UDS assay based on EdU
incorporation was comparable to the conventional auto-
radiographic method; we could distinguish between a
normal and an XP-deﬁcient primary ﬁbroblast when the
cells were co-cultured on a single coverslip. (ii) The assay
was compatible with standard immunostaining and latex-
bead-labeling, which provide proper internal controls.
(iii) The time required for the assay was dramatically
reduced; the entire UDS assay can be completed within
half a day from the preparation of specimen coverslips.
The UDS assay based on EdU could potentially become
a standard technique in NER research as well as XP
diagnosis.
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